Mission is to build transformational human medicine companies that benefit patients and the professionals who serve them. Over half of our portfolio companies were created with our initial investment. We believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health. Find Hatteras Venture Partners on LinkedIn.

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. Delayed at least 20 minutes. Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura. Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference. View all events and presentations.

Sunday, October 18, 2009. We have packed up and moved to the new and improved Life Science Deal Flow. If you have not yet clicked on over to the new site then you are missing out on the wine and cheese being served. While visiting the Life Science Deal Flow. Like the corners of my mind. Memries, may be .

Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build successful management teams, form impactful corporate alliances, win key customers, and navigate acquisitions and IPOs. Biotech VCs Shift Away From Chronic Diseases, Report Says.

Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing. Has insight on what drives success from assessing management and clinical development plans for over 25 years. On what drives success is key to assessing management and their clinical plan.